Daniel Szulczyk

8PUBLICATIONS
23CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsNanotoxicology, health and safetyBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 04, 2026
Machine Learning-Driven QSRR Modeling of Albumin Binding in Fluoroquinolones: An SVR Approach Supported by HSA Chromatography.

|Mar 19, 2026
Discovery of a tetrazole-thiourea derivative as a potential active agent against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis.

Jolanta Szymańska-Majchrzak, Agnieszka Głogowska, Ewa Augustynowicz-Kopeć

|Oct 15, 2025
Synthesis, Cytotoxicity Evaluation, and Molecular Dynamics of 4-Thiazolidinone Derivatives: A Potential Path to EGFR-Targeted Anticancer Therapy.

Tomasz Szostek, Dagmara Otto-Ślusarczyk, Michał A Dobrowolski

|Jul 27, 2024
Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies.

Wioletta Olejarz, Karol Sadowski, Daniel Szulczyk

|Jun 24, 2022
Design and Synthesis of Menthol and Thymol Derived Ciprofloxacin: Influence of Structural Modifications on the Antibacterial Activity and Anticancer Properties.

Tomasz Szostek, Daniel Szulczyk, Jolanta Szymańska-Majchrzak

|Jan 11, 2022
Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase.

Piotr Roszkowski, Jolanta Szymańska-Majchrzak, Michał Koliński

Pageof 2

Frequent Collaborators

4 joint publications

Piotr Roszkowski

4 joint publications

Wioletta Olejarz

4 joint publications

Marta Struga

3 joint publications

Michał A Dobrowolski